24/7 Customer Support

BCG Tuberculosis Vaccine Market - Industry Dynamics, Market Size, And Opportunity Forecast To 2031

Global BCG Tuberculosis Vaccine Market: By Type (Immune BCG and Therapy BCG); Application (Hospital and Clinics); Region— Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2023–2031

  • Published Date: 19-Jun-2023  |   Format: pdfpowerpointexcel  |  Report ID: AA0623469
    Delivery: 2 to 4 Hours
INFOGRAPHIC:
BCG Tuberculosis Vaccine Market

View Full Infographic

REPORT SCOPE

Report AttributeDetails
Market Size Value in 2022US$ 63.58 Million
Expected Revenue in 2031US$ 91.10 Million
Historic Data2018-2021
Base Year2022
Forecast Period2023-2031
UnitValue (USD Mn)
CAGR4.5%
Segments coveredBy Type, By Application, By Region
Key Companies                                                                 Japan BCG Laboratory, China Biotechnology Co., Ltd, Merck KGaA, Serum Institute of India Pvt. Ltd., GSBPL, AJ Vaccines, Statens Serum Institute, Other Prominent players
Customization ScopeGet your customized report as per your preference. Ask for customization

FREQUENTLY ASKED QUESTIONS

The BCG Tuberculosis Vaccine Market was valued at US$ 63.58 Mn in 2022. 

The market is projected to grow at a CAGR of 4.5% during the forecast period (2023-2031).

High prevalence of tuberculosis in the adult population and the growing aging population will increase demand during the predicted period. 

Uncertainty in the supply of raw materials and side effects associated with the vaccine may hinder the growth of the market.

The Global BCG Tuberculosis Vaccine Market is analyzed based on various segmentations such as product type and application.

Initiatives by United Nations (UN) for TB prevention worldwide are expected to provide an opportunity for market growth during the forecast period. 

Based on product type, the market is segmented into immune BCG and therapy BCG. Among these, the immune BCG segment held a majority of the market share.

Based on the application, the market is bifurcated into hospitals and clinics. The hospitals segment constituted a major market share.

The threat of new entrants for existing market players in the BCG tuberculosis vaccine market is moderate due to the presence of a significant number of market players.

In the global BCG tuberculosis vaccine market, the Asia Pacific market is expected to drive the growth of the market. 

The Top players in the market are Japan BCG Laboratory, China Biotechnology Co., Ltd, Merck KGaA, Serum Institute of India Pvt. Ltd., GSBPL, AJ Vaccines, Statens Serum Institute.

LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.

SPEAK TO AN ANALYST